1 of 1
Story summary
- The UK Covid-19 Inquiry credits the rapid vaccine rollout with saving approximately 450,000 lives in England.
- Dexamethasone was identified by the National Health Service (NHS) as a critical drug.
- Dexamethasone reduced mortality among severely ill patients.
- The RECOVERY trial enrolled 10,000 patients early in the pandemic.
- The United Kingdom expedited vaccine approvals for Oxford/AstraZeneca, Pfizer, and Moderna within a year.
